Andrew J. Long

8.7k citations

11 papers · 4.6k indexed · 2 hit papers · h-index 8

Immunology top 0.5%
- T-cell and B-cell Immunology 4
- Immune Cell Function and Interaction 3
- Mast cells and histamine 1
Oncology top 0.5%
- Cytokine Signaling Pathways and Interactions 2
Genetics top 5%
- Chronic Lymphocytic Leukemia Research 3
Hematology top 5%
Pulmonary and Respiratory Medicine top 5%
Rheumatology
- Systemic Lupus Erythematosus Research 2
- Rheumatoid Arthritis Research and Therapies 2
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment 2

Co-authors: Lori Fitz Clive R. Wood Beatriz M. Carreno Tasuku Honjo Hiroyuki Nishimura Vincent Ling Heidi F. Horton Mary Collins
Cited by: Immunology Oncology Genetics
Journals: The Journal of Experimental Medicine (1 paper)Oncogene (1 paper)Frontiers in Immunology (1 paper)
Partner nations: United States Australia Belgium

In The Last Decade

Andrew J. Long

10 papers receiving 4.5k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Andrew J. Long

Since Specialization

Citations

This map shows the geographic impact of Andrew J. Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Long more than expected).

Fields of papers citing papers by Andrew J. Long

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Long. The network helps show where Andrew J. Long may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andrew J. Long, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew J. Long Line = papers co-authored together Andrew J. Long links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work
1	Therapeutic JAK1 Inhibition Reverses Lupus Nephritis in a Mouse Model and Demonstrates Transcriptional Changes Consistent With Human Disease ACR Open Rheumatology ·Rachel Twomey,Stuart J. Perper,Susan V. Westmoreland,Swetha Srinivasan,Suzanne Mathieu,Kristine E. Frank,József Kármán,Andrew J. Long,William Housley,Stephen H. Clarke	2024	0
2	Synovial Inflammatory Pathways Characterize Anti‐TNF–Responsive Rheumatoid Arthritis Patients Arthritis & Rheumatology ·Jing Wang,Donna Conlon,Felice Rivellese,Alessandra Nerviani,Myles Lewis,William Housley,Marc C. Levesque,Xiaohong Cao,Carolyn A. Cuff,Andrew J. Long,Costantino Pitzalis,Melanie C. Ruzek	2022	19
3	The JAK1 Selective Inhibitor ABT 317 Blocks Signaling Through Interferon-γ and Common γ Chain Cytokine Receptors to Reverse Autoimmune Diabetes in NOD Mice Frontiers in Immunology ·Tingting Ge,Gaurang Jhala,Stacey Fynch,Satoru Akazawa,Sara A. Litwak,Evan G. Pappas,Tara Catterall,Ishan Vakil,Andrew J. Long,Lisa M. Olson,Balasubramanian Krishnamurthy,Thomas W. H. Kay,Helen E. Thomas	2020	31
4	FRI0131 ELUCIDATING THE MECHANISM UNDERLYING CREATINE PHOSPHOKINASE UPREGULATION WITH UPADACITINIB Annals of the Rheumatic Diseases ·Kara L. Queeney,William Housley,Jeremy Sokolov,Andrew J. Long	2019	13
5	STAT3 phosphorylation mediates the stimulatory effects of interferon alpha on B cell differentiation and activation in SLE Lara D. Veeken ·Aurélie De Groof,Julie Ducreux,Floor Aleva,Andrew J. Long,Alina Ferster,André van der Ven,Frank L. van de Veerdonk,Frédéric Houssiau,Bernard Lauwerys	2019	13
6	In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)breakdown → BMC Rheumatology ·Julie Parmentier,J W Voss,Candace Graff,Annette Schwartz,M.A. Argiriadi,Michael Friedman,Heidi S. Camp,Robert J. Padley,Jonathan S. George,Deborah Hyland,Matthew Rosebraugh,Neil Wishart,Lisa Olson,Andrew J. Long	2018	276
7	ABBV-105, a selective and irreversible inhibitor of Bruton’s tyrosine kinase, is efficacious in multiple preclinical models of inflammation Modern Rheumatology ·Christian Goess,Christopher M. Harris,Sara Murdock,Richard McCarthy,Erik R. Sampson,Rachel Twomey,Suzanne Mathieu,Regina Mario,Matthew Perham,Eric R. Goedken,Andrew J. Long	2018	26
8	Syk Inhibition Induces Platelet Dependent Peri-islet Hemorrhage in the Rat Pancreas Toxicologic Pathology ·Andrew J. Long,Erik R. Sampson,Richard McCarthy,Christopher M. Harris,Marc R. Barnard,Dan Shi,Donna Conlon,Robert Granville Caldwell,David J. Honor,Neil Wishart,Michael Z. Hoemann,Lori Duggan,Douglas Fritz,Christopher Stedman,Elizabeth O’Connor,Igor Mikaelian,Annette Schwartz	2016	5
9	Concurrent Large Para-oesophageal Hiatal Hernia Repair and Laparoscopic Adjustable Gastric Banding: Results from 5-year Follow Up Obesity Surgery ·Andrew J. Long,Paul R. Burton,Cheryl Laurie,Margaret L. Anderson,Geoff Hebbard,Paul E. O’Brien,Wendy A. Brown	2015	2
10	Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activationbreakdown → The Journal of Experimental Medicine ·Gordon J. Freeman,Andrew J. Long,Yoshiko Iwai,Karen Bourque,Tatyana Chernova,Hiroyuki Nishimura,Lori Fitz,Nelly Malenkovich,Taku Okazaki,Michael C. Byrne,Heidi F. Horton,Lynette A. Fouser,Laura Carter,Vincent Ling,Michael Bowman,Beatriz M. Carreno,Mary Collins,Clive R. Wood,Tasuku Honjo	2000	4158
11	Characterization of murine Flt4 ligand/VEGF-C Oncogene ·Lori Fitz,John C. Morris,Paul Towler,Andrew J. Long,P. R. Burgess,Rita Greco,Jack Wang,Rob Gassaway,Elliott Nickbarg,Sharlotte Kovacic,A. Ciarletta,JoAnn Giannotti,Heather Finnerty,Richard Zollner,David R. Beier,Lee V. Leak,Katherine J. Turner,Clive R. Wood	1997	35

About Andrew J. Long

Andrew J. Long is a scholar working on Genetics, Immunology and Rheumatology, having authored 11 papers that have together received 4.6k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Immune Cell Function and Interaction (3 papers), Systemic Lupus Erythematosus Research (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Mast cells and histamine (1 paper). The work is most often cited by research in Immunology (2.8k citations), Oncology (2.9k citations) and Genetics (217 citations). Andrew J. Long has collaborated with scholars based in United States, Australia and Belgium. Frequent co-authors include Lori Fitz, Clive R. Wood, Beatriz M. Carreno, Tasuku Honjo, Hiroyuki Nishimura, Vincent Ling, Heidi F. Horton, Mary Collins, Michael C. Byrne and Taku Okazaki. Their work appears in journals such as The Journal of Experimental Medicine, Oncogene and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact